Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-694-1 | CAS number: 687-47-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1991-02-15 to 1991-04-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Version / remarks:
- not specified
- Deviations:
- yes
- Remarks:
- not measured: food consumption, haematological and clinical chemistry, organ weight determinations, and microscopical examination of tissues and organs other than the nose.
- Principles of method if other than guideline:
- A sub-acute (28-day) inhalation toxicity study followed by a (28-day) recovery period was conducted in rats to provide data on recovery from, persistence of, or delayed occurrence of toxic effects on the nose. In a previous study (TNO report
no. V 90.322, see IUCLID section 7.5.2), ethyl lactate was irritating and toxic to the lining epithelium of the nasal cavity at levels of 150, 600 and 2500 mg/m³. Since it is necessary for the health risk evaluation of ethyl lactate to obtain a no-toxic effect level, an additional study had to be performed. - GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Ethyl (S)-2-hydroxypropionate
- EC Number:
- 211-694-1
- EC Name:
- Ethyl (S)-2-hydroxypropionate
- Cas Number:
- 687-47-8
- Molecular formula:
- C5H10O3
- IUPAC Name:
- ethyl 2-hydroxypropanoate
Constituent 1
- Specific details on test material used for the study:
- - Name of the test substance: etyhl-(S)(-)-lactate
- Trade name: Purasolv Elect
- Batch number no: EK 3003
- Appearance: clear liquid
- Expiry date: 31-01-1992
- Purity: 99.7%
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Wistar rats (Hsd/Cpb:WU) were obtained from Charles River Wiga, Sulzfeld, FRG
- Age at study initiation: 5-6 weeks old at arrival in the Institute; 6-7 weeks old at the start of the treatment
- Weight at study initiation: 196.7 g (males) and 143.4 g (females)
- Fasting period before study: no, but during exposure both control and test animals had no access to food or water
- Housing: During the acclimatization period (days -7 until -1) and during the main part of the recovery period (days 31-56) the rats were housed in groups of five, separated by sex in suspended, stainless steel cages, fitted with wire mesh floor and front. During the exposure period the rats were housed individually in wire mesh stainless steel cages in a modified H 1000 multitiered inhalation chamber manufactured by Hazleton Systems Inc., USA.
- Diet (e.g. ad libitum): except during exposure, the rats were maintained on the Institute's cereal-based, powdered stock diet for rats, mice and hamsters.
- Water (e.g. ad libitum): except during exposure, community tap water was supplied in glass bottles which were cleaned once weekly
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): generally between 20-24 °C during exposure, and between 19 and 25 °C before and after exposure. Occasionelly, levels of up to 25.5 °C were reached.
- Humidity (%): The relative humidity generally fluctuated between 40-70%, and during several days in inhalation chamber C (75 mg/m³; values of up to 77%). In addition, due to wet cleaning activities the relative humidity exceeded the upper limit, the peaks eaching maxima up to 97% for about half an hour each time.
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Remarks on MMAD:
- MMAD / GSD: vapour
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Animals were exposed to the test atmosphere in modified H1000 multitiered inhalation chambers manufactured by Hazleton Systems Inc., USA. The chambers have a pyramidal top and bottom. The chambers have been constructed of stainless steel with glass doors on two sides which allow observation of the animals during exposure.
- Method of holding animals in test chamber: The rats were housed individually in wire mesh stainless steel cages.
- System of generating particulates/aerosols: To generate the test atmospheres, metered amounts of ethyl lactate were transported by roller pumps (Watson-Marlow 502S/R) to pressurized air driven nebulizers (Lee dispenser, type 110 K, Lee Co., USA). The generated mixture of air and test material was diluted with filtered air till the required concentration was achieved. To allow all particles to mix with air and to evaporate, the animals were located in the cage unit at the right bottom level of each inhalation chamber. Animals in the control group were exposed to freshly filtered air under similar conditions as the test groups.
- Temperature, humidity, pressure in air chamber: The temperature fluctuated between 20-24°C during exposure. The relative humidity generally fluctuated between 40-70%, but during several days in inhalation chamber C (75 mg/m³) values up to 77% were reached. In addition, due to wet cleaning activities the relative humidity exceeded the upper limit, the peeks reaching maxima up to 97% for about half an hour each time. Each chamber was fitted with a micromanometer which showed the negative pressure inside (1-4 mm water column).
- Air flow rate: Airflow was monitored by means of an anemometer (Thermo-Air type 442) and was recorded three times each exposure day. Total airflow through the chambers varied between 38 and 40 m³/hour.
- Air change rate: between 17 and 18 air changes per hour during exposure, otherwise 10 air changes per hour.
TEST ATMOSPHERE
- Brief description of analytical method used: The concentration of the test material was determined by means of a total carbon analyser (Ratfisch RS 55, FRG). Test atmosphere samples were taken sequentially from each of the chambers at a location close to the cage unit in which the animals were housed. The samples were drawn through sampling lines and were passed via a controlled valves system (Kuax-Control, Kuhnke 61.000) to the total carbon analyser. The response of the total carbon analyser was recorded in scale units and converted into concentration values (mg/m³). To ensure that no test material would condensate during sampling transport the sampling lines and the valves system were heated. Each chamber was monitored approximately once each half an hour for about 7 minutes, resulting in about 12 measurements per concentration level per day.
- Samples taken from breathing zone: no - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The concentration of the test material was determined by means of a total carbon analyser (Ratfisch RS 55, FRG). Before the start of the study the response of the flame ionization detector (FID) was calibrated by passing flows of 25, 75, and 200 mg/m³ over the FID. The calibration mixtures corresponding to these flows, were prepared by injecting known quantities of test material (0.7, 2.2, or 5.8 µL) in 40-L teflon bags, which were filled with 30 L of air. After evaporation of the test material and careful mixing with the air, samples were passed to the total carbon analyser. The response of the FID (in scale units) was recorded. The calibration procedure was repeated towards the end of the exposure period. Similar data were obtained. The nominal concentration was determined by dividing the total daily amount of test substance used per treatment group by the total volume of air passed through each exposure unit.
- Duration of treatment / exposure:
- 4 weeks
- Frequency of treatment:
- 6 hours a day, 5 days a week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/m³ air (nominal)
- Remarks:
- Control
- Dose / conc.:
- 25 mg/m³ air (nominal)
- Remarks:
- Low concentration;
Mean daily concentration (analytical): 24 (+/- 1) mg/m³
- Dose / conc.:
- 75 mg/m³ air (nominal)
- Remarks:
- Mid concentration;
Mean daily concentration (analytical): 73 (+/- 5) mg/m³
- Dose / conc.:
- 200 mg/m³ air (nominal)
- Remarks:
- High concentration;
Mean daily concentration (analytical): 202 (+/- 3) mg/m³
- No. of animals per sex per dose:
- 5, for the control and 200 mg/m³ exposure group 5 additional rats/sex were exposed (recovory group).
- Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: In a previous study, ethyl lactate was irritating and toxic to the lining epithelium of the nasal cavity at levels of 150, 600 and 2500 mg/m³. Clinical observations, growth, gross examination at autopsy and microscopical examination of the nose were used as criteria for disclosing possible harmful effects at lower concentrations of 25, 75 and 200 mg/m³.
- Rationale for animal assignment (if not random): One day before the start of the study, the rats were divided over the various groups in such a way that the mean initial body weight was about the same in all groups (< ± 20% of the mean weight). A few rats were replaced by reserve animals in order to equalize the mean initial body weight. Computer randomization according to body weight was not possible because the number of animals in each group was not the same (groups B and C comprised of less animals than groups A and B). Computer randomization was, however, performed upon arrival.
- Rationale for selecting satellite groups: To provide data on recovery from, persistence of, or delayed occurrence of toxic effects on the nose.
- Post-exposure recovery period in satellite groups: Following the exposure period, rats of the recovery groups (Control and 200 mg/m³) were kept for a 28-day period without treatment.
- Section schedule rationale (if not random): On nominal day 28, all rats of the main groups, and on day 56, all rats of the recovery groups, were killed in such a sequence that the average time of killing was about the same for each group. - Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: The general condition and behaviour of all animals were checked at least once daily throughout the study. All signs of ill health, reaction to treatment or mortality were recorded.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Each rat was individually handled and carefully examined for clinical signs, abnormal behaviour or abnormal appearance at the weekly weighing.
BODY WEIGHT: Yes
- Time schedule for examinations: The individual body weights of all rats were recorded during the acclimatization period (day -4), one day before the start of the exposure (allocation procedure), just prior to the first exposure to the test substance (day 0), and subsequent at weekly intervals (including the day of autopsy).
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION: No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: No
CLINICAL CHEMISTRY: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- On nominal day 28, all rats of the main groups, and on nominal day 56, all rats of the recovery groups, were killed in such a sequence that the average time of killing was about the same for each group. The animals were anaesthetized by ether, bied to death by cannulating the abdominal aorta and then examined macroscopically for pathological changes.
GROSS PATHOLOGY: Yes, the animals were examined macroscopically for pathological changes.
HISTOPATHOLOGY: Yes, the nose of all animals was preserved in a neutral, aqueous, phosphate-buffered, 4% solution of formaldehyde, decalcified, embedded in paraffin wax, sectioned at 5 µm and stained with haematoxylin and eosin. Histopathological examination was performed on 4 sections of the nose of each animal. - Statistics:
- Body weight data of the main groups were analysed by one-way analysis of covariance using preexposure (day 0) weights as the covariate. When group means were significantly different (p< 0.05) individual pairwise comparisons were made using Dunnett's multiple comparison method. Body weight data of the recovery groups were analysed by Student t-test. Incidence of histopathological changes were analysed by Fisher's exact probability test. All pairwise comparisons were two tailed. Group mean differences with an associated probability of less than 0.05 were considered to be statistically significant.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- see box "Details on results"
- Mortality:
- no mortality observed
- Description (incidence):
- see box "Details on results"
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- see box "Details on results"
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Endocrine findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- see box "Details on results"
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- see box "Details on results"
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not examined
- Details on results:
- CLINICAL SIGNS AND SURVIVAL
No clinical symptoms or signs of systemic toxicity were observed during the study. All study animals survived to the scheduled sacrifice.
BODY WEIGHTS
There were no statistically significant differences in mean body weights between the test groups and the controls.
GROSS PATHOLOGY
Gross examination of animals of the main groups at autopsy revealed a slightly oedematous and red discoloured thymus in one male of the control
group and in one male of the mid-concentration group. The kidneys of one male of the control group were slightly enlarged and soft. These gross changes are common findings in rats and they are not considered to have any toxicological relevance. One female rat of the mid-concentration group showed a subcutaneous haemorrhage between the eyes, which was most probably caused
by trauma and was not regarded to have any clinical significance. Gross examination of rats of the recovery groups did not reveal any abnormalities.
HISTOPATHOLOGY: NON-NEOPLASTIC
In a few rats of either sex of both the main and the recovery groups (controls included), the respiratory epithelium of the nasal cavity showed minimal changes, seen as nest-like infolds and slight hypertrophy/hyperplasia. The changes were about equally distributed amongst the various groups or occurred in a single animal only. Therefore, the changes were not ascribed to inhalation of ethyl lactate.
Effect levels
open allclose all
- Key result
- Dose descriptor:
- NOAEC
- Remarks:
- local effects
- Effect level:
- 200 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remarks'
- Dose descriptor:
- NOAEC
- Remarks:
- systemic
- Effect level:
- 200 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No adverse systemic effects observed at the high concentration of 200 mg/m³
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Analytical results:
The mean daily concentrations of ethyl lactate in the test atmospheres during exposure were 24 (+/- 1) mg/m³, 73 (+/- 5) mg/m³ and 202 (+/- 3) mg/m³. The actual concentrations were generally close to the intended concentrations.
Applicant's summary and conclusion
- Conclusions:
- In a sub-acute inhalation toxicity study in rats, Ethyl (S)-lactate showed no effects adverse effects. There were no compound related effects in mortality, clinical signs, body weight or gross and histological pathology. Microscopic examination revealed minimal changes (nest-like infolds, slight hypertrophy, and slight hyperplasia) in the nasal respiratory epithelium of animals in all groups, the control group included. Type and incidence of the changes were similar in the various groups, or the changes occurred in a single animal only. These changes were not ascribed to treatment. Based on the results, the NOEC is considered to be 200 mg/m³.
- Executive summary:
In a sub-acute inhalation toxicity study, Ethyl (S)-lactate was administered to 5 male and 5 female Wistar rats/concentration by whole body exposure at concentrations of 0, 0.025, 0.075 and 0.2 mg/L (0, 25, 75 and 200 mg/m³) for 6 hours per day, 5 days/week for a total of 28 days. Two additional (recovery) groups of 5 male and 5 female Wistar rats exposed to 0 or 0.2 mg/ were kept untreated for 28 post-exposure days. Clinical observations, growth, macroscopical observations at autopsy and microscopical examinations of the nose were used as criteria for disclosing possible harmful effects. There were no compound related effects in mortality, clinical signs, body weight or gross and histological pathology. Microscopic examination revealed minimal changes (nest-like infolds, slight hypertrophy, and slight hyperplasia) in the nasal respiratory epithelium of animals in all groups, the control group included. Type and incidence of the changes were similar in the various groups, or the changes occurred in a single animal only. These changes were not ascribed to treatment. Based on the results, the NOAEC is considered to be 200 mg/m³.
In contrast to a previously conducted study (TNO report V 90.322, 1995), in which rats were exposed to 150, 600 or 2500 mg ethyl lactate per m³ for 28 days, the results of the present study show that rats exposed to 25, 75 or 200 mg ethyl lactate per m³ for the same period did not develop compound-related histopathological changes in the nose. The histopathological changes observed at an exposure concentration of 150 mg/m³ (TNO report V 90.322), viz. replacement of olfactory epithelium by respiratory epithelium, goblet cell hypertrophy and moderate goblet cell hyperplasia, were considered to be in line with the changes observed at concentration-response relationship including the response seen at the 150 mg/m³ exposure concentration. The minimal changes observed in the present study consisting of nest-like infolds and slight hypertrophy and hyperplasia are fully comparable to the minimal changes observed at the 150 mg/m³ level of the previous study. However, since in the present study these minimal changes were observed in all groups, controls included, and their incidences in treatment groups were not different from those in the control group, or the changes occurred in a single animal only, these minimal alterations were not ascribed to treatment. Therefore, it is concluded that the no-adverse-effect concentration, as regards to local effects, in the present study is 200 mg/m³, indicating that the level of 150 mg/m³ used in the previous study (TNO report V 90.322, 1995), should be considered a no-adverse-effect concentration as well.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.